Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer-Reference-Cited by-同舟云学术

Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer

Published:2021-01-08 Issue:2 Volume:24 Page:532-541
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Karunamuni Roshan A.^ORCID, ,Huynh-Le Minh-Phuong^ORCID,Fan Chun C.,Thompson Wesley,Eeles Rosalind A.^ORCID,Kote-Jarai Zsofia,Muir Kenneth^ORCID,Lophatananon Artitaya,Schleutker Johanna^ORCID,Pashayan Nora,Batra Jyotsna^ORCID,Grönberg Henrik,Walsh Eleanor I.,Turner Emma L.,Lane Athene,Martin Richard M.^ORCID,Neal David E.,Donovan Jenny L.,Hamdy Freddie C.,Nordestgaard Børge G.,Tangen Catherine M.,MacInnis Robert J.,Wolk Alicja,Albanes Demetrius,Haiman Christopher A.,Travis Ruth C.,Stanford Janet L.,Mucci Lorelei A.,West Catharine M. L.,Nielsen Sune F.,Kibel Adam S.,Wiklund Fredrik^ORCID,Cussenot Olivier,Berndt Sonja I.,Koutros Stella,Sørensen Karina Dalsgaard^ORCID,Cybulski Cezary,Grindedal Eli Marie,Park Jong Y.^ORCID,Ingles Sue A.,Maier Christiane,Hamilton Robert J.,Rosenstein Barry S.,Vega Ana,Kogevinas Manolis,Penney Kathryn L.,Teixeira Manuel R.^ORCID,Brenner Hermann,John Esther M.,Kaneva Radka,Logothetis Christopher J.,Neuhausen Susan L.,Razack Azad,Newcomb Lisa F.,Gamulin Marija^ORCID,Usmani Nawaid,Claessens Frank,Gago-Dominguez Manuela,Townsend Paul A.,Roobol Monique J.^ORCID,Zheng Wei,Mills Ian G.,Andreassen Ole A.^ORCID,Dale Anders M.,Seibert Tyler M.^ORCID, , , , ,

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Urology,Oncology

Link

http://www.nature.com/articles/s41391-020-00311-2.pdf

Reference34 articles.

1. Seibert TM, Fan CC, Wang Y, Zuber V, Karunamuni R, Parsons JK, et al. Polygenic hazard score to guide screening for aggressive prostate cancer: Development and validation in large scale cohorts. BMJ. 2018;360:1–7.

2. Huynh-Le MP, Myklebust TÅ, Feng CH, Karunamuni R, Johannesen TB, Dale AM, et al. Age dependence of modern clinical risk groups for localized prostate cancer—a population-based study. Cancer. 2020;126:1691–9.

3. Pashayan N, Duffy SW, Chowdhury S, Dent T, Burton H, Neal DE, et al. Polygenic susceptibility to prostate and breast cancer: Implications for personalised screening. Br J Cancer. 2011;104:1656–63.

4. Witte JS. Personalized prostate cancer screening: improving PSA tests with genomic information. Sci Transl Med. 2010;2:1–5.

5. Chen H, Liu X, Brendler CB, Ankerst DP, Leach RJ, Goodman PJ, et al. Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trial. Prostate. 2016;76:1120–9.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Review of Family History, Race/Ethnicity, and Genetic Risk on Prostate Cancer Detection and Outcomes: Considerations in PSA-based Screening;Urologic Oncology: Seminars and Original Investigations;2024-07

2. Healthy lifestyle and prostate cancer risk in the Million Veteran Program;Cancer;2024-06-12

3. Assessing the Clinical Utility of Published Prostate Cancer Polygenic Risk Scores in a Large Biobank Data Set;European Urology Oncology;2024-05

4. Prostate cancer in Latin America and the Caribbean: mortality trends from 1997 to 2017 and predictions to 2030;Salud Pública de México;2024-04-29

5. Risk factor control and incident cardiovascular disease in patients with diabetes: Sex‐specific relations;Diabetes, Obesity and Metabolism;2024-01-16